Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Neurologic Disorders Therapeutics Market Status and Forecast (2017-2028)
  • 1.3.2 Global Neurologic Disorders Therapeutics Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Neurologic Disorders Therapeutics Supply by Company

• 2.1 Global Neurologic Disorders Therapeutics Sales Value by Company
• 2.2 Neurologic Disorders Therapeutics Sales Area of Main Manufacturers
• 2.3 Trend of Concentration Rate

3 Global and Regional Neurologic Disorders Therapeutics Market Status by Type

• 3.1 Neurologic Disorders Therapeutics Type Introduction
  • 3.1.1 Central Nervous System (CNS)
  • 3.1.2 Peripheral Nervous System (PNS)
• 3.2 Global Neurologic Disorders Therapeutics Market by Type
• 3.3 North America: by Type
• 3.4 Europe: by Type
• 3.5 Asia Pacific: by Type
• 3.6 Central & South America: by Type
• 3.7 Middle East & Africa: by Type

4 Global and Regional Neurologic Disorders Therapeutics Market Status by Application

• 4.1 Neurologic Disorders Therapeutics Segment by Application
  • 4.1.1 Paralysis
  • 4.1.2 Muscle Weakness
  • 4.1.3 Poor Coordination
  • 4.1.4 Loss of Sensation
  • 4.1.5 Seizures
  • 4.1.6 Confusion
  • 4.1.7 Pain and Altered Levels of Consciousness
• 4.2 Global Neurologic Disorders Therapeutics Market by Application
• 4.3 North America: by Application
• 4.4 Europe: by Application
• 4.5 Asia Pacific: by Application
• 4.6 Central & South America: by Application
• 4.7 Middle East & Africa: by Application

5 Global Neurologic Disorders Therapeutics Market Status by Region

• 5.1 Global Neurologic Disorders Therapeutics Market by Region
• 5.2 North America Neurologic Disorders Therapeutics Market Status
• 5.3 Europe Neurologic Disorders Therapeutics Market Status
• 5.4 Asia Pacific Neurologic Disorders Therapeutics Market Status
• 5.5 Central & South America Neurologic Disorders Therapeutics Market Status
• 5.6 Middle East & Africa Neurologic Disorders Therapeutics Market Status

6 North America Neurologic Disorders Therapeutics Market Status

• 6.1 North America Neurologic Disorders Therapeutics Market by Country
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Neurologic Disorders Therapeutics Market Status

• 7.1 Europe Neurologic Disorders Therapeutics Market by Country
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Neurologic Disorders Therapeutics Market Status

• 8.1 Asia Pacific Neurologic Disorders Therapeutics Market by Country
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Neurologic Disorders Therapeutics Market Status

• 9.1 Central & South America Neurologic Disorders Therapeutics Market by Country
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Neurologic Disorders Therapeutics Market Status

• 10.1 Middle East & Africa Neurologic Disorders Therapeutics Market by Country
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Major Downstream Customers Analysis

• 11.1 Customer One Analysis
• 11.2 Customer Two Analysis
• 11.3 Customer Three Analysis
• 11.4 Customer Four Analysis

12 Global Neurologic Disorders Therapeutics Market Forecast by Type and by Application

• 12.1 Global Neurologic Disorders Therapeutics Sales Value Forecast (2023-2028)
• 12.2 Global Neurologic Disorders Therapeutics Forecast by Type
• 12.3 Global Neurologic Disorders Therapeutics Forecast by Application

13 Global Neurologic Disorders Therapeutics Market Forecast by Region/Country

• 13.1 Global Neurologic Disorders Therapeutics Market Forecast by Region (2023-2028)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 Pfizer Inc.
  • 14.1.1 Company Information
  • 14.1.2 Neurologic Disorders Therapeutics Product Introduction
  • 14.1.3 Pfizer Inc. Neurologic Disorders Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.1.4 SWOT Analysis
• 14.2 Novartis AG
  • 14.2.1 Company Information
  • 14.2.2 Neurologic Disorders Therapeutics Product Introduction
  • 14.2.3 Novartis AG Neurologic Disorders Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.2.4 SWOT Analysis
• 14.3 Johnson & Johnson Services Inc.
  • 14.3.1 Company Information
  • 14.3.2 Neurologic Disorders Therapeutics Product Introduction
  • 14.3.3 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.3.4 SWOT Analysis
• 14.4 F. Hoffmann-La Roche Ltd.
  • 14.4.1 Company Information
  • 14.4.2 Neurologic Disorders Therapeutics Product Introduction
  • 14.4.3 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.4.4 SWOT Analysis
• 14.5 Biogen Inc.
  • 14.5.1 Company Information
  • 14.5.2 Neurologic Disorders Therapeutics Product Introduction
  • 14.5.3 Biogen Inc. Neurologic Disorders Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.5.4 SWOT Analysis

...

15 Conclusion

16 Methodology

This report provides a comprehensive analysis of current global Neurologic Disorders Therapeutics market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Neurologic Disorders Therapeutics industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Neurologic Disorders Therapeutics market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Neurologic Disorders Therapeutics Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Neurologic Disorders Therapeutics market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Neurologic Disorders Therapeutics Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Neurologic Disorders Therapeutics industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
Central Nervous System (CNS)
Peripheral Nervous System (PNS)

Segmented by Application
Paralysis
Muscle Weakness
Poor Coordination
Loss of Sensation
Seizures
Confusion
Pain and Altered Levels of Consciousness

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Pfizer Inc.
Novartis AG
Johnson & Johnson Services Inc.
F. Hoffmann-La Roche Ltd.
Biogen Inc.